Summit Therapeutics Inc.
(SMMT)
undefined
undefined%
At close: undefined
17.63
0.91%
After-hours Jan 06, 2025, 07:57 PM EST
Summit Therapeutics Inc. Revenue Breakdown
| Quarter | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|
| License and Service Revenue | 220.00K | 235.00K | 250.00K | 251.00K | 1.31M | 57.00K | 192.00K | 185.00K | 181.00K |
| License and Service Revenue Growth | -6.38% | -6.00% | -0.40% | -80.83% | +2196.49% | -70.31% | +3.78% | +2.21% | n/a |
Revenue by Geography
| Quarter | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|
| Latin America Revenue | 705.00K | 1.81M | 860.00K | 457.00K |
| Latin America Revenue Growth | -61.03% | +110.35% | +88.18% | n/a |
Operating Expense Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Jan 31, 2019 | Oct 31, 2018 | Jul 31, 2018 | Apr 30, 2018 | Jan 31, 2018 | Oct 31, 2017 | Jul 31, 2017 | Apr 30, 2017 | Jan 31, 2017 | Oct 31, 2016 | Jul 31, 2016 | Apr 30, 2016 | Jan 31, 2016 | Oct 31, 2015 | Jul 31, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 20.39M | 13.95M | 11.73M | 11.61M | 5.43M | 6.32M | 6.94M | 7.54M | 5.57M | 6.93M | 6.66M | 7.78M | 5.66M | 5.98M | 4.18M | 3.84M | 7.46M | 5.30M | 798.54K | 2.58M | 5.63M | 1.46M | 2.14M | 3.96M | 5.92M | 3.56M | 3.67M | 7.21M | 2.62M | 3.27M | 3.15M | 3.78M | 2.33M | 2.52M | 2.09M | 1.98M | 2.01M | 1.56M | 1.66M | 1.97M |
| Selling, General, and Administrative Revenue Growth | +46.15% | +18.94% | +1.02% | +113.65% | -13.96% | -8.99% | -7.90% | +35.21% | -19.62% | +4.11% | -14.41% | +37.41% | -5.38% | +42.99% | +8.98% | -48.53% | +40.78% | +563.59% | -69.05% | -54.21% | +284.78% | -31.59% | -46.01% | -33.04% | +66.48% | -3.25% | -49.05% | +175.61% | -19.97% | +3.90% | -16.82% | +62.57% | -7.78% | +20.60% | +5.48% | -1.17% | +28.40% | -5.72% | -15.86% | n/a |
| Research and Development Revenue | 37.72M | 30.80M | 30.87M | 24.81M | 15.32M | 9.45M | 9.88M | 5.39M | 17.05M | 9.01M | 20.56M | 23.11M | 16.13M | 19.72M | 14.70M | 12.26M | 14.39M | 11.48M | 14.89M | 6.38M | 9.32M | 10.60M | 10.70M | 12.51M | 10.42M | 12.44M | 15.50M | 14.02M | 9.81M | 8.69M | 6.51M | 5.99M | 4.83M | 7.13M | 7.02M | 7.12M | 6.95M | 6.59M | 4.83M | 4.18M |
| Research and Development Revenue Growth | +22.49% | -0.24% | +24.42% | +61.94% | +62.13% | -4.37% | +83.49% | -68.41% | +89.27% | -56.18% | -11.04% | +43.27% | -18.21% | +34.14% | +19.86% | -14.76% | +25.31% | -22.88% | +133.50% | -31.59% | -12.10% | -0.89% | -14.50% | +20.13% | -16.26% | -19.74% | +10.56% | +42.88% | +12.95% | +33.40% | +8.69% | +24.03% | -32.29% | +1.55% | -1.31% | +2.46% | +5.40% | +36.38% | +15.58% | n/a |